Lannett Enters Into Distribution Agreement For Dantrolene Capsules, Commences Product Launch

PHILADELPHIA, June 28, 2019 -- (Healthcare Sales & Marketing Network) -- Lannett Company, Inc. (NYSE: LCI) today announced that it has entered into a three-year agreement with Elite Pharmaceuticals to be the exclusive U.S. distributor of a Dantrolene Caps... Biopharmaceuticals, Generics, Distribution, Product Launch Lannett, Elite Pharmaceuticals, Dantrolene, Dantrium
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news